HIMS SEC Filing News — Hims & Hers Health, Inc.

Latest SEC filings for Hims & Hers Health, Inc. (HIMS) explained in plain English. Covers insider buying and selling (Form 4), proposed insider sales (Form 144), material company events (8-K), and quarterly & annual reports (10-Q / 10-K). StrongBuyAnalytics provides navigation and brief excerpts or summaries; original filings remain at the SEC/source links and were authored by their filers, not StrongBuyAnalytics. Filing dates shown are source dates. Coverage and detection can be delayed or incomplete because of SEC availability, amendments, parsing, caching, or outages. Latest source filing date shown: 2026-10-15.

Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, Australia, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personaliz…
Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic Market Cap: $6.8B CIK: 1773751
20
Total Filings
0
Bullish Classifications
9
Bearish Classifications
10
Insider Transactions
1
Material Events (8-K)
0
Periodic Reports
Rule-based classifications for HIMS currently lean bearish. Of the 20 filing records displayed, 9 carry bearish classifications (such as insider sales or negative 8-K disclosures) versus 0 bullish. This does not necessarily signal fundamental deterioration — insiders sell for many reasons — but it is worth monitoring alongside the company's core financial metrics.
HIMS Filing Activity Snapshot 2026-08-27 — 2026-10-15
Insider Transactions (Form 4)
0 buys vs 9 sells
Net insider selling in this period — insiders sell for many reasons beyond conviction.
Largest Form 144 Filing
$876.8K
Okupe Oluyemi (Chief Financial Officer) · 2026-09-23
29,277 shares · Form 4
Form 144 Notices
9
Proposed insider sales filed — Form 144 is a notice of intent, not a confirmed transaction. Actual sales are confirmed via Form 4.
Insider Transactions 10 · Forms 3, 4 and 5

A Form 4 is filed within two business days of a company insider — an officer, a director, or a holder of more than ten percent of the stock — changing their position in the shares. All 10 filings in this group are Form 4s for Hims & Hers Health, Inc.

The difficulty with reading these filings as a group is that a single form type covers transactions that mean entirely different things. An executive spending their own money to buy stock and an executive having shares withheld to pay tax on a vesting grant both appear as a Form 4. Every filing below is therefore tagged with the nature of the underlying transaction, taken from the transaction code reported on the form itself.

Across the 10 insider filings shown, the breakdown is 9 open-market sale and 1 gift. 9 of them involved a discretionary open-market trade; the rest are compensation and administrative mechanics.

What each transaction type means

Open-market sale ×9
The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.
Gift ×1
Shares were transferred as a gift, typically for estate or charitable planning. No sale into the market took place.
Form 4 Open-market sale Insider Selling 2026-10-15

HIMS insider Boughton Soleil (Chief Legal Officer) sold 3,461 shares (~$100.6K)

Boughton Soleil, listed as Chief Legal Officer at Hims & Hers Health, Inc., reported an open-market sale of 3,461 HIMS shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 3,461 $29.06 $100.6K
Filing: Form 4 (Insider Transaction) Insider: Boughton Soleil (Chief Legal Officer) Shares: 3,461 Est. Value: $100.6K
View on SEC EDGAR → Open Filing Document →
Form 4 Open-market sale Insider Selling 2026-10-02

HIMS insider Okupe Oluyemi (Chief Financial Officer) sold 2,000 shares (~$59.4K)

Okupe Oluyemi, listed as Chief Financial Officer at Hims & Hers Health, Inc., reported an open-market sale of 2,000 HIMS shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 2,000 $29.70 $59.4K
Filing: Form 4 (Insider Transaction) Insider: Okupe Oluyemi (Chief Financial Officer) Shares: 2,000 Est. Value: $59.4K
View on SEC EDGAR → Open Filing Document →
Form 4 Open-market sale Insider Selling 2026-10-02

HIMS insider Boughton Soleil (Chief Legal Officer) sold 3,461 shares (~$101.0K)

Boughton Soleil, listed as Chief Legal Officer at Hims & Hers Health, Inc., reported an open-market sale of 3,461 HIMS shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 3,461 $29.17 $101.0K
Filing: Form 4 (Insider Transaction) Insider: Boughton Soleil (Chief Legal Officer) Shares: 3,461 Est. Value: $101.0K
View on SEC EDGAR → Open Filing Document →
Form 4 Open-market sale Insider Selling 2026-09-23

HIMS insider Okupe Oluyemi (Chief Financial Officer) sold 29,277 shares (~$876.8K)

Okupe Oluyemi, listed as Chief Financial Officer at Hims & Hers Health, Inc., reported an open-market sale of 29,277 HIMS shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
M Option exercise 14,000 $5.01 $70.1K
S Open-market sale 29,277 $29.95 $876.8K
M Option exercise derivative · Stock Option (right to buy) 14,000 — —
Filing: Form 4 (Insider Transaction) Insider: Okupe Oluyemi (Chief Financial Officer) Shares: 29,277 Est. Value: $876.8K
View on SEC EDGAR → Open Filing Document →
Form 4 Open-market sale Insider Selling 2026-09-18

HIMS insider Okupe Oluyemi (Chief Financial Officer) sold 12,313 shares (~$354.9K)

Okupe Oluyemi, listed as Chief Financial Officer at Hims & Hers Health, Inc., reported an open-market sale of 12,313 HIMS shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 12,313 $28.82 $354.9K
Filing: Form 4 (Insider Transaction) Insider: Okupe Oluyemi (Chief Financial Officer) Shares: 12,313 Est. Value: $354.9K
View on SEC EDGAR → Open Filing Document →
Form 4 Open-market sale Insider Selling 2026-09-17

HIMS insider Boughton Soleil (Chief Legal Officer) sold 6,236 shares (~$173.7K)

Boughton Soleil, listed as Chief Legal Officer at Hims & Hers Health, Inc., reported an open-market sale of 6,236 HIMS shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 6,236 $27.86 $173.7K
Filing: Form 4 (Insider Transaction) Insider: Boughton Soleil (Chief Legal Officer) Shares: 6,236 Est. Value: $173.7K
View on SEC EDGAR → Open Filing Document →
Form 4 Open-market sale Insider Selling 2026-09-17

HIMS insider Chi Michael (Chief Operating Officer) sold 14,027 shares (~$398.2K)

Chi Michael, listed as Chief Operating Officer at Hims & Hers Health, Inc., reported an open-market sale of 14,027 HIMS shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 14,027 $28.39 $398.2K
Filing: Form 4 (Insider Transaction) Insider: Chi Michael (Chief Operating Officer) Shares: 14,027 Est. Value: $398.2K
View on SEC EDGAR → Open Filing Document →
Form 4 Open-market sale Insider Selling 2026-09-17

HIMS insider Elshenawy Mohamed (CTO) sold 7,954 shares (~$225.8K)

Elshenawy Mohamed, listed as CTO at Hims & Hers Health, Inc., reported an open-market sale of 7,954 HIMS shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 7,954 $28.39 $225.8K
Filing: Form 4 (Insider Transaction) Insider: Elshenawy Mohamed (CTO) Shares: 7,954 Est. Value: $225.8K
View on SEC EDGAR → Open Filing Document →
Form 4 Open-market sale Insider Selling 2026-09-03

HIMS insider Boughton Soleil (Chief Legal Officer) sold 3,458 shares (~$98.0K)

Boughton Soleil, listed as Chief Legal Officer at Hims & Hers Health, Inc., reported an open-market sale of 3,458 HIMS shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 3,458 $28.33 $98.0K
Filing: Form 4 (Insider Transaction) Insider: Boughton Soleil (Chief Legal Officer) Shares: 3,458 Est. Value: $98.0K
View on SEC EDGAR → Open Filing Document →
Form 4 Gift Tax / Compensation Filing 2026-08-27

HIMS insider Form 4 filed for equity award, exercise, or tax withholding

Dudum Andrew (Director, Chief Executive Officer, 10% Owner) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were transferred as a gift, typically for estate or charitable planning. No sale into the market took place.

Transactions reported on this filing
Code Nature Shares Price Value
G Gift 463,289 — —
J Other transaction 977,566 — —
Filing: Form 4 (Insider Transaction) Insider: Dudum Andrew (Director, Chief Executive Officer, 10% Owner) Shares: 1,440,855
View on SEC EDGAR → Open Filing Document →
Proposed Insider Sales 9 · Form 144

A Form 144 is a notice of intent to sell restricted or control securities. It is not a record that anything was sold. Hims & Hers Health, Inc. has 9 such notices in this period.

The distinction matters because a Form 144 is frequently reported as though it were a completed insider sale. The filer may sell all of the shares covered, some of them, or none at all, and there is no obligation to update the notice either way. A sale that is actually executed by an officer or director shows up separately on a Form 4, which is the filing to check before treating a proposed sale as a real one.

Form 144 Proposed Insider Sale 2026-10-14

HIMS Form 144 filed for proposed insider sale by Boughton Soleil (3,461 shares) ~$100.6K

Boughton Soleil filed a Form 144 with the SEC indicating intent to sell HIMS (Hims & Hers Health, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: Boughton Soleil Shares: 3,461 Est. Value: $100.6K
View on SEC EDGAR → Open Filing Document →
Form 144 Proposed Insider Sale 2026-10-01

HIMS Form 144 filed for proposed insider sale by Okupe Oluyemi (2,000 shares) ~$59.4K

Okupe Oluyemi filed a Form 144 with the SEC indicating intent to sell HIMS (Hims & Hers Health, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: Okupe Oluyemi Shares: 2,000 Est. Value: $59.4K
View on SEC EDGAR → Open Filing Document →
Form 144 Proposed Insider Sale 2026-09-30

HIMS Form 144 filed for proposed insider sale by Boughton Soleil (3,461 shares) ~$101.0K

Boughton Soleil filed a Form 144 with the SEC indicating intent to sell HIMS (Hims & Hers Health, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: Boughton Soleil Shares: 3,461 Est. Value: $101.0K
View on SEC EDGAR → Open Filing Document →
Form 144 Proposed Insider Sale 2026-09-22

HIMS Form 144 filed for proposed insider sale by Okupe Oluyemi (29,277 shares) ~$876.8K

Okupe Oluyemi filed a Form 144 with the SEC indicating intent to sell HIMS (Hims & Hers Health, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: Okupe Oluyemi Shares: 29,277 Est. Value: $876.8K
View on SEC EDGAR → Open Filing Document →
Form 144 Proposed Insider Sale 2026-09-17

HIMS Form 144 filed for proposed insider sale by Okupe Oluyemi (12,313 shares) ~$354.9K

Okupe Oluyemi filed a Form 144 with the SEC indicating intent to sell HIMS (Hims & Hers Health, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: Okupe Oluyemi Shares: 12,313 Est. Value: $354.9K
View on SEC EDGAR → Open Filing Document →
Form 144 Proposed Insider Sale 2026-09-16

HIMS Form 144 filed for proposed insider sale by Boughton Soleil (6,236 shares) ~$173.7K

Boughton Soleil filed a Form 144 with the SEC indicating intent to sell HIMS (Hims & Hers Health, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: Boughton Soleil Shares: 6,236 Est. Value: $173.7K
View on SEC EDGAR → Open Filing Document →
Form 144 Proposed Insider Sale 2026-09-15

HIMS Form 144 filed for proposed insider sale by Elshenawy Mohamed (7,954 shares) ~$225.8K

Elshenawy Mohamed filed a Form 144 with the SEC indicating intent to sell HIMS (Hims & Hers Health, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: Elshenawy Mohamed Shares: 7,954 Est. Value: $225.8K
View on SEC EDGAR → Open Filing Document →
Form 144 Proposed Insider Sale 2026-09-15

HIMS Form 144 filed for proposed insider sale by Chi Michael (14,027 shares) ~$398.2K

Chi Michael filed a Form 144 with the SEC indicating intent to sell HIMS (Hims & Hers Health, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: Chi Michael Shares: 14,027 Est. Value: $398.2K
View on SEC EDGAR → Open Filing Document →
Form 144 Proposed Insider Sale 2026-09-02

HIMS Form 144 filed for proposed insider sale by Boughton Soleil (3,458 shares) ~$98.0K

Boughton Soleil filed a Form 144 with the SEC indicating intent to sell HIMS (Hims & Hers Health, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: Boughton Soleil Shares: 3,458 Est. Value: $98.0K
View on SEC EDGAR → Open Filing Document →
Material Events 1 · Form 8-K

An 8-K reports a material event in the window between scheduled reports. There is 1 in this period for Hims & Hers Health, Inc. Each 8-K names the item number it is filed under, and that number is the fastest way to tell a routine disclosure from a consequential one.

Item 2.02 is an earnings release, Item 5.02 is a change of directors or officers, and Item 1.01 or 2.01 covers a material agreement or a completed acquisition. Item 7.01 and Item 8.01 are the general-purpose disclosure items and carry no fixed meaning on their own.

Form 8-K Material Company Update 2026-10-07

HIMS filed 8-K — material company event

Hims & Hers Health, Inc. filed an 8-K with the SEC reporting a material event. Summary unavailable — view the original SEC filing for the full text.

Filing: 8-K (Material Event)
View on SEC EDGAR → Open Filing Document →

How we classify Hims & Hers Health, Inc.'s filings

Straight from EDGAR

Each displayed record links to an original source document. StrongBuyAnalytics provides navigation and brief excerpts or summaries, not the filing itself. Parsing may omit context or contain errors, so read the original document in full.

Transaction codes, not guesswork

The nature shown on each insider filing comes from the transaction code the filer entered on the form itself — P for an open-market purchase, A for a compensation award, F for shares withheld to pay tax, M for an option exercise. Where one filing contains several codes, the transaction table lists them line by line.

Why the distinction matters

Insider activity is routinely summarised as buying or selling, which flattens together decisions that mean very different things. Shares withheld for tax on a vesting grant are an automatic administrative step; shares bought on the open market are someone committing their own money at the current price.

What this page does not tell you

A filing records what happened, not why. Form 4 does not always disclose whether a sale was executed under a pre-arranged Rule 10b5-1 plan, and no single filing is a basis for a decision on HIMS. Read these alongside the fundamentals rather than in isolation.

Frequently Asked Questions — HIMS SEC Filings

More Tools for HIMS

HIMS Full Stock Analysis HIMS Live Chart Institutional Ownership Earnings Calendar Options Flow Scanner Semiconductor Demand Zone Tracker Sector Scanner Browse All Stocks

Want deeper HIMS analysis?

View valuation, growth metrics, the rule-based stock-page score, demand zones, peer comparison, and more — all on the HIMS stock analysis page.

HIMS Full Analysis
Publisher, sources & limitations — September 15, 2026. StrongBuyAnalytics provides navigation and brief excerpts or summaries for educational use. Original filings remain at SEC EDGAR or other displayed source links; StrongBuyAnalytics does not author them. Filing dates are source dates, not publication dates for this page. Coverage can be delayed, incomplete, amended, or unavailable because of SEC/source availability, parsing, caching, or outages. Verify every material statement in the original filing.
Data Sources · Methodology · AI Disclosure · Corrections Policy · Disclaimer